Abstract

It is now well established that regulatory T (T(R)) cells can inhibit harmful immunopathological responses directed against self or foreign antigens. However, many key aspects of T(R) cell biology remain unresolved, especially with regard to their antigen specificities and the cellular and molecular pathways involved in their development and mechanisms of action. We will review here recent findings in these areas, outline a model for how T(R) cells may inhibit the development of immune pathology and discuss potential therapeutic benefits that may arise from the manipulation of T(R) cell function.

Keywords

Immune systemBiologyImmunologyAntigenT cellFunction (biology)Cell biology

MeSH Terms

AbataceptAnimalsAntigensCDAntigensDifferentiationAutoimmune DiseasesCTLA-4 AntigenCell AdhesionCytokinesHumansImmunoconjugatesMiceModelsImmunologicalReceptorsInterleukin-2Self ToleranceT-Lymphocyte SubsetsT-LymphocytesRegulatoryThymus Gland

Affiliated Institutions

Related Publications

Blockade of Interleukin-6 Signaling Suppresses Not Only Th17 but Also Interphotoreceptor Retinoid Binding Protein–Specific Th1 by Promoting Regulatory T Cells in Experimental Autoimmune Uveoretinitis

PURPOSE. Both Th17 and Th1 cells contribute to experimental autoimmune uveoretinitis (EAU). Interleukin-6 (IL-6) blockade inhibits Th17 differentiation in EAU and potently suppr...

2011 Investigative Ophthalmology & Visual ... 73 citations

Publication Info

Year
2001
Type
review
Volume
2
Issue
9
Pages
816-822
Citations
1181
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1181
OpenAlex
38
Influential
896
CrossRef

Cite This

Kevin J. Maloy, Fiona Powrie (2001). Regulatory T cells in the control of immune pathology. Nature Immunology , 2 (9) , 816-822. https://doi.org/10.1038/ni0901-816

Identifiers

DOI
10.1038/ni0901-816
PMID
11526392

Data Quality

Data completeness: 81%